{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:01:47Z","timestamp":1774119707925,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T00:00:00Z","timestamp":1379721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00259-013-2556-y","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T16:33:08Z","timestamp":1379694788000},"page":"1922-1924","source":"Crossref","is-referenced-by-count":3,"title":["Combined 18F-fluoride and 18F-FDG PET\/CT: a response based on actual data from prospective studies"],"prefix":"10.1007","volume":"40","author":[{"given":"Andrei","family":"Iagaru","sequence":"first","affiliation":[]},{"given":"Camila","family":"Mosci","sequence":"additional","affiliation":[]},{"given":"David W.","family":"Dick","sequence":"additional","affiliation":[]},{"given":"Mike","family":"Sathekge","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Lapa","sequence":"additional","affiliation":[]},{"given":"Joao M.","family":"de Lima","sequence":"additional","affiliation":[]},{"given":"Sanjiv Sam","family":"Gambhir","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,9,21]]},"reference":[{"key":"2556_CR1","doi-asserted-by":"crossref","unstructured":"Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease (authors Gang Cheng & Thomas C. Kwee & Sandip Basu & Abass Alavi) Eur J Nucl Med Mol Imaging (2013) 40:1141\u20131145 doi: 10.1007\/s00259-013-2459-y","DOI":"10.1007\/s00259-013-2459-y"},{"key":"2556_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2967\/jnumed.112.108803","volume":"54","author":"A Iagaru","year":"2013","unstructured":"Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, et al. Combined 18F-fluoride and 18F-FDG PET\/CT scanning for evaluation of malignancy: results of an international multicenter trial. J Nucl Med. 2013;54:176\u201383. doi: 10.2967\/jnumed.112.108803 .","journal-title":"J Nucl Med"},{"key":"2556_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.108.058339","volume":"50","author":"A Iagaru","year":"2009","unstructured":"Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, et al. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET\/CT scan for evaluation of malignancy: results of the pilot-phase study. J Nucl Med. 2009;50:501\u20135. doi: 10.2967\/jnumed.108.058339 .","journal-title":"J Nucl Med"},{"key":"2556_CR4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00259-011-1971-1","volume":"39","author":"F Lin","year":"2012","unstructured":"Lin F, Rao J, Mittra E, Nallapareddy K, Chengapa A, Dick D, et al. Prospective comparison of combined 18F-FDG and 18F-NaF PET\/CT vs. 18F-FDG PET\/CT imaging for detection of malignancy. Eur J Nucl Med Mol Imaging. 2012;39:262\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2556_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.109.066910","volume":"51","author":"D Bailey","year":"2010","unstructured":"Bailey D. Combined (18)F-FDG and fluoride approach in PET\/CT imaging: is there a clinical future? J Nucl Med. 2010;51:165\u20136.","journal-title":"J Nucl Med"},{"key":"2556_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.109.066860","volume":"51","author":"S Basu","year":"2010","unstructured":"Basu S, Rao R. Combined (18)F-FDG and fluoride approach in PET\/CT imaging: is there a clinical future? J Nucl Med. 2010;51:165.","journal-title":"J Nucl Med"},{"key":"2556_CR7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2967\/jnumed.109.067082","volume":"51","author":"A Iagaru","year":"2010","unstructured":"Iagaru A, Mittra E, Goris ML, Gambhir SS. Reply: combined 18F-FDG and fluoride approach in PET\/CT imaging: is there a clinical future? J Nucl Med. 2010;51:166\u20137. doi: 10.2967\/jnumed.109.067082 .","journal-title":"J Nucl Med"},{"key":"2556_CR8","first-page":"287","volume":"47","author":"E Even-Sapir","year":"2006","unstructured":"Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT. J Nucl Med. 2006;47:287\u201397.","journal-title":"J Nucl Med"},{"key":"2556_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.semnuclmed.2009.05.002","volume":"39","author":"S Ben Haim","year":"2009","unstructured":"Ben Haim S, Israel O. Breast cancer: role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:408\u201315.","journal-title":"Semin Nucl Med"},{"key":"2556_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MNM.0b013e3283412ef5","volume":"32","author":"N Withofs","year":"2011","unstructured":"Withofs N, Grayet B, Tancredi T, Rorive A, Mella C, Giacomelli F, et al. 18F-fluoride PET\/CT for assessing bone involvement in prostate and breast cancers. Nucl Med Commun. 2011;32:168\u201376.","journal-title":"Nucl Med Commun"},{"key":"2556_CR11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11307-011-0486-2","volume":"14","author":"A Iagaru","year":"2012","unstructured":"Iagaru A, Mittra E, Dick D, Gambhir S. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET\/CT, and (18)F FDG PET\/CT for detection of skeletal metastases. Mol Imaging Biol. 2012;14:252\u20139.","journal-title":"Mol Imaging Biol"},{"key":"2556_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00256-003-0623-3","volume":"32","author":"F Feldman","year":"2003","unstructured":"Feldman F, van Heertum R, Manos C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003;32:201\u20138.","journal-title":"Skeletal Radiol"},{"key":"2556_CR13","first-page":"1485","volume":"10","author":"H Jadvar","year":"2003","unstructured":"Jadvar H, Pinski J, Conti P. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003;10:1485\u20138.","journal-title":"Oncol Rep"},{"key":"2556_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12149-011-0551-6","volume":"26","author":"M Shiiba","year":"2012","unstructured":"Shiiba M, Ishihara K, Kimura G, Kuwako T, Yoshihara N, Sato H, et al. Evaluation of primary prostate cancer using 11C-methionine-PET\/CT and 18F-FDG-PET\/CT. Ann Nucl Med. 2012;26:138\u201345.","journal-title":"Ann Nucl Med"},{"key":"2556_CR15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/RLU.0b013e318252d829","volume":"37","author":"H Jadvar","year":"2012","unstructured":"Jadvar H, Desai B, Ji L, Conti P, Dorff T, Groshen S, et al. Prospective evaluation of 18F-NaF and 18F-FDG PET\/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clin Nucl Med. 2012;37:637\u201343.","journal-title":"Clin Nucl Med"},{"key":"2556_CR16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00259-009-1181-2","volume":"36","author":"S Kr\u00fcger","year":"2009","unstructured":"Kr\u00fcger S, Buck A, Mottaghy F, Hasenkamp E, Pauls S, Schumann C, et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2009;36:1807\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2556_CR17","first-page":"1800","volume":"42","author":"H Schirrmeister","year":"2001","unstructured":"Schirrmeister H, Glatting G, Hetzel J, N\u00fcssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800\u20134.","journal-title":"J Nucl Med"},{"key":"2556_CR18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0033-8389(22)00824-7","volume":"26","author":"MD Jones","year":"1988","unstructured":"Jones MD, Pais MJ, Omiya B. Bony overgrowths and abnormal calcifications about the spine. Radiol Clin North Am. 1988;26:1213\u201334.","journal-title":"Radiol Clin North Am"},{"issue":"Suppl 1","key":"2556_CR19","first-page":"586","volume":"53","author":"S Sampath","year":"2012","unstructured":"Sampath S, Sampath S, Lutz A, Willmann J, Mittra E, Gambhir S, et al. Evaluation of NaF PET\/CT, FDG PET\/CT, combined NaF\/FDG PET\/CT and CT alone for detection of bone metastases. J Nucl Med. 2012;53 Suppl 1:586, abstract.","journal-title":"J Nucl Med"},{"key":"2556_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1148\/radiology.209.1.9769840","volume":"209","author":"S Hoegerle","year":"1998","unstructured":"Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Radiology. 1998;209:253\u20138.","journal-title":"Radiology"},{"issue":"Suppl 1","key":"2556_CR21","first-page":"2455","volume":"52","author":"K Richmond","year":"2011","unstructured":"Richmond K, McLean N, Rold T, Szczodroski A, Dresser T, Hoffman T. Optimizing a F-18 NaF and FDG cocktail as a preclinical cancer screening tool for molecular imaging. J Nucl Med. 2011;52 Suppl 1:2455. Abstract.","journal-title":"J Nucl Med"},{"key":"2556_CR22","first-page":"1836","volume":"36","author":"JW Keyes","year":"1995","unstructured":"Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836\u20139.","journal-title":"J Nucl Med"},{"key":"2556_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"M Adams","year":"2010","unstructured":"Adams M, Turkington T, Wilson J, Wong T. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310\u201320.","journal-title":"AJR Am J Roentgenol"},{"key":"2556_CR24","first-page":"885","volume":"47","author":"D Delbeke","year":"2006","unstructured":"Delbeke D, Coleman RE, Guiberteau M, Brown M, Royal H, Siegel B, et al. Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0. J Nucl Med. 2006;47:885\u201395.","journal-title":"J Nucl Med"},{"key":"2556_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty M, Weber W, Mottaghy F, Lonsdale M, Stroobants S, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2556_CR26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2967\/jnumed.112.112177","volume":"54","author":"RD Niederkohr","year":"2013","unstructured":"Niederkohr RD, Greenspan BS, Prior JO, Sch\u00f6der H, Seltzer MA, Zukotynski KA, et al. Reporting guidance for oncologic 18F-FDG PET\/CT imaging. J Nucl Med. 2013;54:756\u201361. doi: 10.2967\/jnumed.112.112177 .","journal-title":"J Nucl Med"},{"key":"2556_CR27","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.2007.14.5631","volume":"26","author":"B Hillner","year":"2008","unstructured":"Hillner B, Siegel B, Liu D, Shields A, Gareen I, Hanna L, et al. Impact of positron emission tomography\/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155\u201361.","journal-title":"J Clin Oncol"},{"key":"2556_CR28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","volume":"37","author":"E Even Sapir","year":"2007","unstructured":"Even Sapir E, Mishani E, Flusser G, Metser U. 18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography. Semin Nucl Med. 2007;37:462\u20139.","journal-title":"Semin Nucl Med"},{"key":"2556_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2011.09.053","volume":"50","author":"Y Li","year":"2012","unstructured":"Li Y, Schiepers C, Lake R, Dadparvar S, Berenji G. Clinical utility of (18)F-fluoride PET\/CT in benign and malignant bone diseases. Bone. 2012;50:128\u201339.","journal-title":"Bone"},{"key":"2556_CR30","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00259-005-1890-0","volume":"32","author":"T Kazama","year":"2005","unstructured":"Kazama T, Swanston N, Podoloff D, Macapinlac H. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging. 2005;32:1406\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2556_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00259-011-2012-9","volume":"39","author":"R Niederkohr","year":"2012","unstructured":"Niederkohr R. Technical feasibility vs. clinical utility: a question of \u201ccan we?\u201d vs. \u201cshould we?\u201d. Eur J Nucl Med Mol Imaging. 2012;39:260\u20131.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2556_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.112.116236","volume":"54","author":"GJR Cook","year":"2013","unstructured":"Cook GJR. Combined 18F-fluoride and 18F-FDG PET\/CT scanning for evaluation of malignancy: results of an International Multicenter Trial. J Nucl Med. 2013;54:173\u20135. doi: 10.2967\/jnumed.112.116236 .","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2556-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:56:00Z","timestamp":1715993760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,21]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2556-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,21]]}}}